Income statement
USD
Annual
| Metric | 2010 |
|---|---|
| Revenue | 0 |
| Gross Profit | -6K |
| Operating Income | -103K |
| EBITDA | -97K |
| Net Income | -134K |
| EPS (Diluted) | — |
Basic Materials
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 242 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Therma-Med, Inc. (THRA) is a Basic Materials stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC -69.2%. Stock Foundry combines THRA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THRA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THRA Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for THRA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$133.8K
Free Cash Flow
-$60.0K
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2010 |
|---|---|
| Revenue | 0 |
| Gross Profit | -6K |
| Operating Income | -103K |
| EBITDA | -97K |
| Net Income | -134K |
| EPS (Diluted) | — |
Balance sheet
USD
| Metric | 2010 |
|---|---|
| Cash & Equivalents | 0 |
| Total Assets | 150K |
| Total Liabilities | 147K |
| Shareholder Equity | 3K |
| Total Debt | 126K |
| Net Debt | 126K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
60K
Capital Expenditures
0
Free Cash Flow
60K
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-4990.6%
Debt / Equity
47.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.